ASM joined partners in submitting the following request to Congress.
Dear Chairman Leahy, Vice Chairman Shelby, Chair Murray and Ranking Member Blunt
cc: Chair DeLauro, Ranking Member Granger and Ranking Member Cole:
We, the undersigned organizations, respectfully request that you provide $60 million for the Advanced Molecular Detection (AMD) program at the Centers for Disease Control and Prevention (CDC) in the Fiscal Year (FY) 2022 Labor, Health and Human Services, Education and Related Agencies bill. The AMD program uses next generation sequencing (NGS) to bring the concept of precision medicine to bear for “precision public health.”
AMD gives us new tools to detect disease faster, identify outbreaks sooner, and protect people from emerging and evolving disease threats. It informs vaccine development, helps identify and track antimicrobial resistance and foodborne illness, and informs the development of diagnostics for new, existing and emerging diseases. AMD has played a
Lab stakeholders welcome Biden moves on COVID-19 testing, suggest additional steps
Adam Bonislawski
doctor, lab, laboratory, medical, medicine, chemistry, test tube, dna, deney
With President Joseph Biden taking office this week, the lab industry is keen to see what steps his administration will take to boost COVID testing.
Last week he released details on his $1.9 trillion American Rescue Plan, a legislative package that would include $50 billion to expand COVID-19 testing and an additional $30 billion investment in the Disaster Relief Fund to help ramp up production of supplies including items like vials, reagents, and protective gear that are essential to collecting and running clinical samples.